Shockwave Therapy Plus Exercise for Lateral Epicondylitis

NCT07282431 | Active Not Recruiting

• 1 other identifier: MST-1
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

The primary objective of this study is to compare the clinical effectiveness of exercise therapy alone versus exercise combined with Extracorporeal Shock Wave Therapy (ESWT) in individuals with lateral epicondylitis, focusing on changes in pain, grip strength, functional status, and overall treatment success.

Conditions

Lateral Epicondylitis

Keywords

Lateral epicondylitis Extracorporeal Shock Wave Therapy

Outcome Measures

Primary Outcomes (2)

• Extracorporeal Shock Wave Therapy (ESWT) applied in addition to exercise does not create a significant difference in pain level, grip strength and functional status in individuals with lateral epicondylitis compared to exercise alone.

  Pain Intensity (Visual Analog Scale - VAS) Description: Pain intensity will be assessed using the Visual Analog Scale, a 10-cm line ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will mark their perceived pain level on the line. Time Frame: Baseline and 8 weeks Outcome Type: Continuous Interpretation: Higher scores indicate worse pain.

  8 week

• Upper Extremity Function (Quick Disabilities of the Arm, Shoulder and Hand Questionnaire - QuickDASH)

  Upper Extremity Function (Quick Disabilities of the Arm, Shoulder and Hand Questionnaire - QuickDASH) Description: Functional status will be measured using the QuickDASH questionnaire. Scores range from 0 (no disability) to 100 (severe disability). Time Frame: Baseline and 8 weeks Outcome Type: Continuous Interpretation: Higher scores indicate worse functional impairment.

  8 week

Study Arms (2)

Control Group

EXPERIMENTAL

Participants will be randomly assigned to two groups; one group will receive exercise therapy alone,

Other: exercise therapy

Extracorporeal Shock Wave Therapy (ESWT)

EXPERIMENTAL

Participants will be randomly assigned to two groups; one group will receive exercise therapy alone, while the other group will receive exercise plus Extracorporeal Shock Wave Therapy (ESWT). Clinical efficacy will be assessed by pre- and post-treatment measurements.

Other: Extracorporeal Shock Wave Therapy (ESWT)

Interventions

Extracorporeal Shock Wave Therapy (ESWT) OTHER

Extracorporeal Shock Wave Therapy (ESWT)

Extracorporeal Shock Wave Therapy (ESWT)

exercise therapy OTHER

exercise therapy

Control Group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Being 18 years of age or older
• Having a clinical diagnosis of lateral epicondylitis
• Not having received any other similar treatment within the last 6 months
• Having the cognitive ability to understand the Turkish questionnaire and assessment forms
• Voluntarily agreeing to participate in the study and providing written informed consent

You may not qualify if:

• Having a history of concomitant systemic, rheumatological, or inflammatory diseases that could affect pain
• Having a history of trauma, surgery, or neurological disease in the upper extremity
• Presence of conditions other than lateral epicondylitis, such as tendinopathy, bursitis, or nerve entrapment
• Having major psychiatric disorders that could affect the pain threshold (e.g., major depression, schizophrenia)

Sponsors & Collaborators

• Istanbul Medipol University Hospital: lead

Study Sites (1)

Istanbul medipol University

Istanbul, Beykoz, 34000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Tennis Elbow

Interventions

Extracorporeal Shockwave Therapy; Exercise Therapy

Condition Hierarchy (Ancestors)

Elbow Tendinopathy; Tendinopathy; Muscular Diseases; Musculoskeletal Diseases; Elbow Injuries; Arm Injuries; Wounds and Injuries; Tendon Injuries

Intervention Hierarchy (Ancestors)

Ultrasonic Therapy; Diathermy; Hyperthermia, Induced; Therapeutics; Physical Therapy Modalities; Rehabilitation; Aftercare; Continuity of Patient Care; Patient Care

Study Officials

• Salih tan, doctorate

  Medipol University

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Doctorate

Study Record Dates

• First Submitted: November 16, 2025
• First Posted: December 15, 2025
• Study Start: June 15, 2025
• Primary Completion: January 15, 2026
• Study Completion: February 15, 2026
• Last Updated: December 15, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)